CN1626169A - 鱼腥草鼻用制剂及其生产工艺 - Google Patents
鱼腥草鼻用制剂及其生产工艺 Download PDFInfo
- Publication number
- CN1626169A CN1626169A CN 200310111552 CN200310111552A CN1626169A CN 1626169 A CN1626169 A CN 1626169A CN 200310111552 CN200310111552 CN 200310111552 CN 200310111552 A CN200310111552 A CN 200310111552A CN 1626169 A CN1626169 A CN 1626169A
- Authority
- CN
- China
- Prior art keywords
- herba houttuyniae
- parts
- distillate
- nasal formulations
- nasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013717 Houttuynia Nutrition 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title description 5
- 240000000691 Houttuynia cordata Species 0.000 title description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 18
- 239000011780 sodium chloride Substances 0.000 claims abstract description 9
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 230000001954 sterilising effect Effects 0.000 claims abstract description 7
- 239000008213 purified water Substances 0.000 claims abstract description 5
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 58
- 238000009472 formulation Methods 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 27
- 239000003814 drug Substances 0.000 claims description 22
- XJLDYKIEURAVBW-UHFFFAOYSA-N 3-decanone Chemical compound CCCCCCCC(=O)CC XJLDYKIEURAVBW-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 10
- 238000005516 engineering process Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- 235000010265 sodium sulphite Nutrition 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 6
- 238000001256 steam distillation Methods 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 3
- 229940033663 thimerosal Drugs 0.000 claims description 3
- 239000008215 water for injection Substances 0.000 claims description 2
- 206010039083 rhinitis Diseases 0.000 abstract description 25
- 241000758769 Houttuynia Species 0.000 abstract 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 abstract 1
- -1 antiseptic Chemical compound 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 abstract 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 15
- 201000009890 sinusitis Diseases 0.000 description 14
- 238000002347 injection Methods 0.000 description 13
- 239000007924 injection Substances 0.000 description 13
- 210000001331 nose Anatomy 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000001154 acute effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 239000007923 nasal drop Substances 0.000 description 5
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 201000009151 chronic rhinitis Diseases 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 201000009240 nasopharyngitis Diseases 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000002850 nasal mucosa Anatomy 0.000 description 3
- CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 description 2
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 206010039088 Rhinitis atrophic Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 229960002179 ephedrine Drugs 0.000 description 2
- 238000011169 microbiological contamination Methods 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 210000003695 paranasal sinus Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000007910 systemic administration Methods 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- XLYLQUQHYUOPIW-UHFFFAOYSA-N 3-oxo-Tetradecanal Chemical compound CCCCCCCCCCCC(=O)CC=O XLYLQUQHYUOPIW-UHFFFAOYSA-N 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- QBDCOUHKEVYWLO-UHFFFAOYSA-N Decanoylacetaldehyde Natural products CCCCCCCCCC(=O)CC=O QBDCOUHKEVYWLO-UHFFFAOYSA-N 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 206010015943 Eye inflammation Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010050515 Hyposmia Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 201000002014 Suppurative Otitis Media Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003097 anti-respiratory effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000019559 hyposmia Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 229960005016 naphazoline Drugs 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
鼻炎类型 | 病例数 | 显效 | 有效 | 无效 | 有效率 |
急慢性鼻炎 | 361 | 283 | 75 | 3 | 99.2% |
急慢性鼻窦炎 | 293 | 192 | 96 | 5 | 98.3% |
干燥性鼻炎 | 80 | 56 | 20 | 4 | 95.0% |
萎缩性鼻炎 | 67 | 45 | 21 | 1 | 98.5% |
合计 | 801 | 576 | 212 | 13 | 98.4% |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310111552 CN1272044C (zh) | 2003-12-11 | 2003-12-11 | 鱼腥草鼻用制剂及其生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310111552 CN1272044C (zh) | 2003-12-11 | 2003-12-11 | 鱼腥草鼻用制剂及其生产工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1626169A true CN1626169A (zh) | 2005-06-15 |
CN1272044C CN1272044C (zh) | 2006-08-30 |
Family
ID=34759422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200310111552 Expired - Lifetime CN1272044C (zh) | 2003-12-11 | 2003-12-11 | 鱼腥草鼻用制剂及其生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1272044C (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106581256A (zh) * | 2016-12-30 | 2017-04-26 | 河南科技大学 | 一种用于治疗鼻窦炎的中药组合物、药物制剂及其制备方法 |
CN107137502A (zh) * | 2016-03-01 | 2017-09-08 | 北京盈科瑞药物研究院有限公司 | 一种鱼腥草雾化吸入用溶液制剂及其制备方法 |
CN111671887A (zh) * | 2020-07-27 | 2020-09-18 | 李秀华 | 一种综合特效治疗慢性鼻炎的中西药配方及治疗方法 |
-
2003
- 2003-12-11 CN CN 200310111552 patent/CN1272044C/zh not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107137502A (zh) * | 2016-03-01 | 2017-09-08 | 北京盈科瑞药物研究院有限公司 | 一种鱼腥草雾化吸入用溶液制剂及其制备方法 |
CN112957350A (zh) * | 2016-03-01 | 2021-06-15 | 神威药业集团有限公司 | 一种鱼腥草雾化吸入用溶液制剂及其制备方法 |
CN106581256A (zh) * | 2016-12-30 | 2017-04-26 | 河南科技大学 | 一种用于治疗鼻窦炎的中药组合物、药物制剂及其制备方法 |
CN106581256B (zh) * | 2016-12-30 | 2020-02-18 | 河南科技大学 | 一种用于治疗鼻窦炎的中药组合物、药物制剂及其制备方法 |
CN111671887A (zh) * | 2020-07-27 | 2020-09-18 | 李秀华 | 一种综合特效治疗慢性鼻炎的中西药配方及治疗方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1272044C (zh) | 2006-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103301254B (zh) | 一种鼻咽腔道用抗菌液及其制备方法 | |
CN105848664A (zh) | 用于治疗持续性咳嗽的组合物 | |
CN1272044C (zh) | 鱼腥草鼻用制剂及其生产工艺 | |
CN104147465B (zh) | 一种中药止嗽制剂 | |
CN1589852A (zh) | 治疗感冒的外用滴鼻剂及制备方法 | |
CN112121116A (zh) | 一种天然植物活性因子抗抑菌雾化剂及其制备方法 | |
CN1263470C (zh) | 治疗感冒的外用滴鼻剂及制备方法 | |
CN112472669A (zh) | 一种基于红辣椒提取物和肝素预防流感的鼻腔喷雾剂及其制备方法 | |
CN102670855B (zh) | 一种治疗鼻后滴流综合征的中药组合物及其制备方法 | |
CN107149611B (zh) | 一种蒙药鼻炎喷雾剂及其制备方法 | |
CN1150931C (zh) | 用于治疗感冒、流感的双金莲口服液及其制备方法 | |
CN114404527B (zh) | 一种用于治疗呼吸道感染的中药组合物 | |
CN100415244C (zh) | 鼻炎鼻窦炎滴鼻液 | |
CN110115739A (zh) | 一种治疗病毒感染性疾病或咳嗽变异型哮喘的中药组合物及其制备方法 | |
CN1221253C (zh) | 茶多酚在治疗呼吸系统疾病的药物中的应用 | |
CN1166389C (zh) | 一种治疗伤风感冒的喷雾剂及其制备方法 | |
CN1162179C (zh) | 一种治疗鼻炎的药剂及其制备方法 | |
CN1274325C (zh) | 治疗感冒的滴鼻剂及制备方法 | |
CN109223956B (zh) | 一种用于治疗咳嗽的中药组合物及其提取方法与应用 | |
CN1274327C (zh) | 治疗感冒的滴鼻剂及制备方法 | |
CN1253002A (zh) | 抗感冒口服液及其生产工艺 | |
CN115998715A (zh) | 一种中药材中挥发油气化吸入人体的治疗方法 | |
CN1112200C (zh) | 一种主治急慢性鼻炎的中药滴鼻剂及其制作方法 | |
CN100406030C (zh) | 治疗口腔溃疡的中药制剂及其制备方法 | |
CN112891452A (zh) | 一种治疗咽炎的组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Wuhan Changlian Laifu Biochemical Pharmaceutical Co.,Ltd. Assignor: TONGJI HOSPITAL TONGJI MEDICAL College HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY Contract fulfillment period: 2008.1.8 to 2013.1.7 Contract record no.: 2009420010073 Denomination of invention: Cordate houttuynia preparation taken through nose Granted publication date: 20060830 License type: Exclusive license Record date: 20091228 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.1.8 TO 2013.1.7; CHANGE OF CONTRACT Name of requester: WUHAN CHANGLIAN LAIFU BIOCHEMICAL PHARMACEUTICAL C Effective date: 20091228 |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Wuhan Changlian Laifu Biochemical Pharmaceutical Co.,Ltd. Assignor: TONGJI HOSPITAL TONGJI MEDICAL College HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY Contract record no.: 2009420010073 Date of cancellation: 20140711 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
ASS | Succession or assignment of patent right |
Owner name: WUHAN TONGJI MODERN PHARMACEUTICAL TECHNOLOGY CO., Free format text: FORMER OWNER: TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE, HUAZHONG SCIENCE + TECHNOLOG Effective date: 20140910 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430030 WUHAN, HUBEI PROVINCE TO: 430056 WUHAN, HUBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140910 Address after: 430056 No. 22 hi tech Industrial Park, Wuhan economic and Technological Development Zone, Hubei Patentee after: WUHAN TONGJI MODERN PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Address before: 430030 No. 1095 Liberation Road, Hankou, Hubei (Tongji Hospital, Wuhan Research Institute) Patentee before: TONGJI HOSPITAL TONGJI MEDICAL College HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Cordate houttuynia nasal preparation and its production process Effective date of registration: 20201117 Granted publication date: 20060830 Pledgee: Hubei Guo Chuang financing Company limited by guarantee Pledgor: WUHAN TONGJI MODERN PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Registration number: Y2020980008077 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220328 Granted publication date: 20060830 Pledgee: Hubei Guo Chuang financing Company limited by guarantee Pledgor: WUHAN TONGJI MODERN PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Registration number: Y2020980008077 |
|
CX01 | Expiry of patent term |
Granted publication date: 20060830 |
|
CX01 | Expiry of patent term |